Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.76 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 2/20 | 0.35 |
| ▸ | MITF | O75030 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | HK1 | P19367 | 1/20 | 0.33 |
| ▸ | HK2 | P52789 | 1/20 | 0.33 |
| ▸ | HRAS | P01112 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8718037 | 1.00 | KMT2A (0.76) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL5532821 | 1.00 | KMT2A (0.76) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL7570134 | 1.00 | KMT2A (0.76) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL12195138 | 1.00 | KMT2A (0.76) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL8584208 | 0.96 | KMT2A (0.70) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL18095977 | 0.91 | KMT2A (0.63) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL21778853 | 0.89 | KMT2A (0.62) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL24236918 | 0.86 | KMT2A (0.69) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL7150056 | 0.86 | KMT2A (0.69) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL12930889 | 0.86 | KMT2A (0.69) | KMT2AMEN1L3MBTL1ALDH1A1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2382226-B1 | PROCESS FOR THE SYNTHESIS OF L-FUCOSYL DI- OR OLIGOSACCHARIDES AND NOVEL 2,3,4 TRIBENZYL-FUCOSYL DERIVATIVES INTERMEDIATES THEREOF | INALCO SPA (IT) | 2013-12-04 | — | — | EP | disclosed |
| EP-2471802-A1 | Phosphoramidates of monosaccharides | Bioiberica, S.A. (ES) | 2012-07-04 | — | — | EP | disclosed |
| US-20110245488-A1 | PROCESS FOR THE SYNTHESIS OF L-FUCOSYL DI- OR OLIGO-SACCHARIDES AND NOVEL 2,3,4 TRIBENZYL-FUCOSYL DERIVATIVES INTERMEDIATES THEREOF | INALCO S.P.A. (IT) | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110245488-A1 | PROCESS FOR THE SYNTHESIS OF L-FUCOSYL DI- OR OLIGO-SACCHARIDES AND NOVEL 2,3,4 TRIBENZYL-FUCOSYL DERIVATIVES INTERMEDIATES THEREOF | FUCA2, FUT5, FUT6 | KMT2A 3764/4885MEN1 4544/4885L3MBTL1 1447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.